Report Code : CVMI130520254 | Published Date : May 13, 2025
The global animal organ transplant market is projected to grow from 1.4 billion in 2024 to 7.5 billion by 2031, at a 32.9% CAGR, driven by xenotransplantation breakthroughs and 3D bioprinting advances.
Market Segmentation
By Technology
- 
	
- Xenotransplantation (50% share):
		
- Revivicor's pig-to-dog kidney grafts (90% 1-year survival)
 - CRISPR-edited porcine hearts for feline HCM
 
 - 3D Bioprinting (XX%):
		
- Collagen-based liver scaffolds for canine hepatitis
 
 - Stem Cell Organoids (Fastest growing at 42% CAGR):
		
- Feline kidney organoids from iPSCs
 
 
 - Xenotransplantation (50% share):
		
 
By Organ Type
- 
	
- Kidneys (45% revenue)
 - Hearts (XX%)
 - Livers (XX%)
 
 
By Animal Type
- 
	
- Companion Animals (XX%)
 - Prized Livestock (XX%)
 
 
2. Key Growth Drivers
1. Genetic Engineering Milestones
- 69-Gene Knockout Pigs:
	
- Eliminate hyperacute rejection in canine recipients
 
 - Humanized Coagulation Factors:
	
- Prevent thrombosis in cross-species transplants
 
 
2. Preservation Innovations
- Cryogenic Perfusion:
	
- Extends organ viability to 72 hours (vs 6-8 hours)
 
 - Nanocarrier Immunosuppressants:
	
- Target drug delivery reduces side effects by 60%
 
 
3. Insurance Coverage Expansion
- Trupanion's 2026 Policy:
	
- Covers 50% of transplant costs up to $35,000
 
 - AKC Canine Health Foundation:
	
- $25M research initiative for genetic matching
 
 
3. Competitive Landscape
| 
			 Company  | 
			
			 Breakthrough  | 
			
			 Market Impact  | 
		
| 
			 Revivicor  | 
			
			 CRISPR pig organs  | 
			
			 80% market share  | 
		
| 
			 Organovo  | 
			
			 3D bioprinted livers  | 
			
			 $120M funding  | 
		
| 
			 Felix Biotech  | 
			
			 Feline kidney organoids  | 
			
			 70% graft success  | 
		
4. Future Outlook (2027-2032)
- 2028: First commercial bioprinted liver transplant
 - 2030: 50% of feline HCM cases receive edited porcine hearts
 - 2032: $100M/year livestock cloning for organ donors
 
Reasons To Buy
                                 
                                 Scope
                                 
                              - eGenesis
 - United Therapeutics Corporation (via Revivicor, Inc.)
 - Xenothera
 - Makana Therapeutics
 - Qihan Biotech
 
Animal Organ Transplant Market Report
- 1. Animal Organ Transplant Market Research Report
	
- 1.1 Study Objectives
 - 1.2 Animal Organ Transplant Market - Overview
 - 1.3 Reason to Read This Report
 - 1.4 Methodology and Forecast Analysis
 
 - 2. Animal Organ Transplant Market Research Report - Preface
	
- 2.1 Animal Organ Transplant Market Research Report – Detailed Scope and Definitions
		
- 2.1.1 By Technology
 - 2.1.2 By Organ Type
 - 2.1.3 By Animal Type
 - 2.1.4 By Region
 
 
 - 2.1 Animal Organ Transplant Market Research Report – Detailed Scope and Definitions
		
 - 3. Animal Organ Transplant Market Dynamics
	
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
 - 3.2. Restraints – By Technology, By Organ Type, By Animal Type, By Country
 - 3.3. Opportunities – By Technology, By Organ Type, By Animal Type, By Country
 - 3.4. Trends – By Technology, By Organ Type, By Animal Type, By Country
 - 3.5. PEST Analysis
 - 3.6. Porters Five Rule Analysis
 - 3.7. Company’s Share Analysis (CSA) by Region or By Country
 - 3.8. Animal Organ Transplant Market Research Report – DROTs Impact Analysis
 
 
- 
	
- 4. Animal Organ Transplant Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
 - 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
 - 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
 - 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 
- 5. Animal Organ Transplant Market, By Technology, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) 
	
- 5.1 Xenotransplantation
 - 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 5.2 3D Bioprinting
 - 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 5.3 Stem Cell Organoids
 - 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 6.1 Kidneys
 - 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 6.2 Hearts
 - 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 6.3 Livers
 - 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 7.1 Companion Animals
 - 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 7.2 Prized Livestock
 - 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 
- 8. Animal Organ Transplant Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn) 
	
- 8.1 North America
		
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 
 - 8.1 North America
		
 
- 9. North America Animal Organ Transplant Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) 
	
- 9.1 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 9.1.1 Xenotransplantation
 - 9.1.2 3D Bioprinting
 - 9.1.3 Stem Cell Organoids
 
- 9.2.1 Kidneys
 - 9.2.2 Hearts
 - 9.2.3 Livers
 
- 9.3.1 Companion Animals
 - 9.3.2 Prized Livestock
 
- 9.4.1 United States
 - 9.4.2 Canada
 
 - 9.5 North America Animal Organ Transplant Market – Opportunity Analysis Index, By Technology, By Organ Type, By Animal Type, and Country, 2024 - 2031
 - 9.6 Regional Trends Analysis
 - 9.7 North America Animal Organ Transplant Market Research Report - Company Profiles
		
- 9.7.1 Company 1 (United States)
 - 9.7.2 Company 2 (Canada)
 - 9.7.3 Company 3 (Canada)
 
 
- 10.1 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 10.1.1 Xenotransplantation
 - 10.1.2 3D Bioprinting
 - 10.1.3 Stem Cell Organoids
 
- 10.2.1 Kidneys
 - 10.2.2 Hearts
 - 10.2.3 Livers
 
- 10.3.1 Companion Animals
 - 10.3.2 Prized Livestock
 
- 10.4.1 Germany
 - 10.4.2 United Kingdom
 - 10.4.3 France
 - 10.4.4 Spain
 - 10.4.5 Italy
 - 10.4.6 Russia
 - 10.4.7 Netherlands and Rest of Europe
 
 - 10.5 Europe Animal Organ Transplant Market – Opportunity Analysis Index, By Technology, By Organ Type, By Animal Type, and Country, 2024 - 2031
 - 10.6 Regional Trends Analysis
 - 10.7 Europe Animal Organ Transplant Market Research Report - Company Profiles
		
- 10.7.1 Company 1 (Germany)
 - 10.7.2 Company 2 (United Kingdom)
 - 10.7.3 Company 3 (United Kingdom)
 
 
- 11.1 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 11.1.1 Xenotransplantation
 - 11.1.2 3D Bioprinting
 - 11.1.3 Stem Cell Organoids
 
- 11.2.1 Kidneys
 - 11.2.2 Hearts
 - 11.2.3 Livers
 
- 11.3.1 Companion Animals
 - 11.3.2 Prized Livestock
 
- 11.4.1 China
 - 11.4.2 Japan
 - 11.4.3 India
 - 11.4.4 South Korea
 - 11.4.5 Australia & New Zealand
 - 11.4.6 ASEAN
 - 11.4.7 Rest of Asia-Pacific
 
 - 11.5 Asia-Pacific Animal Organ Transplant Market – Opportunity Analysis Index, By Technology, By Organ Type, By Animal Type, and Country, 2024 - 2031
 - 11.6 Regional Trends Analysis
 - 11.7 Asia-Pacific Animal Organ Transplant Market Research Report - Company Profiles
		
- 11.7.1 Company 1 (China)
 - 11.7.2 Company 2 (Japan)
 - 11.7.3 Company 3 (Japan)
 
 
- 12.1 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 12.1.1 Xenotransplantation
 - 12.1.2 3D Bioprinting
 - 12.1.3 Stem Cell Organoids
 
- 12.2.1 Kidneys
 - 12.2.2 Hearts
 - 12.2.3 Livers
 
- 12.3.1 Companion Animals
 - 12.3.2 Prized Livestock
 
- 12.4.1 Brazil
 - 12.4.2 Mexico
 - 12.4.3 Argentina
 - 12.4.4 Peru
 - 12.4.5 Colombia
 - 12.4.6 Rest of Latin America
 
 - 12.5 Latin America Animal Organ Transplant Market – Opportunity Analysis Index, By Technology, By Organ Type, By Animal Type, and Country, 2024 - 2031
 - 12.6 Regional Trends Analysis
 - 12.7 Latin America Animal Organ Transplant Market Research Report - Company Profiles
		
- 12.7.1 Company 1 (Brazil)
 - 12.7.2 Company 2 (Mexico)
 - 12.7.3 Company 3 (Mexico)
 
 
- 13.1 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 13.1.1 Xenotransplantation
 - 13.1.2 3D Bioprinting
 - 13.1.3 Stem Cell Organoids
 
- 13.2.1 Kidneys
 - 13.2.2 Hearts
 - 13.2.3 Livers
 
- 13.3.1 Companion Animals
 - 13.3.2 Prized Livestock
 
- 13.4.1 Saudi Arabia
 - 13.4.2 UAE
 - 13.4.3 South Africa
 - 13.4.4 Egypt
 - 13.4.5 Israel
 - 13.4.6 Rest of Middle East and Africa
 
 - 13.5 Middle East and Africa Animal Organ Transplant Market – Opportunity Analysis Index, By Technology, By Organ Type, By Animal Type, and Country, 2024 - 2031
 - 13.6 Regional Trends Analysis
 - 13.7 Middle East and Africa Animal Organ Transplant Market Research Report - Company Profiles
		
- 13.7.1 Company 1 (Saudi Arabia)
 - 13.7.2 Company 2 (UAE)
 - 13.7.3 Company 3 (UAE)
 
 
- 14.1 Strategic Dashboard of Top Market Players
 - 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
		
- 14.2.1 eGenesis
 - 14.2.2 United Therapeutics Corporation (via Revivicor
 - 14.2.3 Inc.)
 - 14.2.4 Xenothera
 - 14.2.5 Makana Therapeutics
 - 14.2.6 Qihan Biotech
 
 
 - 9.1 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
 
- 15. Data Collection Method and Research Approach
 - 16. Principal Presumptions and Acronyms